drugset / Trial / NCT01511003

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

NCT01511003 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study is to assess efficacy and safety of tacrolimus in active rheumatoid arthritis patients who showed unsuccessful response to existing DMARDs.

Timeline

Start
2011-12-05
Primary completion
2015-05-11
Completion
2015-05-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — Oral

Indications